Cart
sales@molnova.com
Kajiichigoside F1
CAS No. 95298-47-8
Kajiichigoside F1( —— )
Catalog No. M31605 CAS No. 95298-47-8
Kaji-ichigoside F1 shows antiinflammatory/antinociceptive action in acetic acid-induced writhing and hot plate testing and in a carrageenan-induced paw edema model in mice and rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 744 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameKajiichigoside F1
-
NoteResearch use only, not for human use.
-
Brief DescriptionKaji-ichigoside F1 shows antiinflammatory/antinociceptive action in acetic acid-induced writhing and hot plate testing and in a carrageenan-induced paw edema model in mice and rats.
-
DescriptionKaji-ichigoside F1 shows antiinflammatory/antinociceptive action in acetic acid-induced writhing and hot plate testing and in a carrageenan-induced paw edema model in mice and rats. Kaji-ichigoside F1 exhibits in vivo hepatoprotective effects, it inhibited d-GalN-induced cytotoxicity in primary cultured mouse hepatocytes with the IC50 of14.1uM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number95298-47-8
-
Formula Weight650.84
-
Molecular FormulaC36H58O10
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4-hydroxy-3-methylbe...
4-Hydroxy-3-methylbenzoic acid is a normal organic acid identified in urine specimens from a healthy population.
-
Sodium Molybdate
Sodium molybdate is a useful source of molybdate. In murine models Sodium molybdate dihydrate inactivated both the active and inactive form of the glucocorticoid receptor complex.
-
Anethole trithione
Anethole trithione is a drug used in the treatment of dry mouth, being studied in the treatment of Y.
